关注
Yingluo Liu
标题
引用次数
引用次数
年份
Identification of metabolic vulnerabilities of receptor tyrosine kinases-driven cancer
N Jin, A Bi, X Lan, J Xu, X Wang, Y Liu, T Wang, S Tang, H Zeng, Z Chen, ...
Nature Communications 10 (1), 2701, 2019
972019
Discovery of Novel Pyrrolo[2,3-d]pyrimidine-based Derivatives as Potent JAK/HDAC Dual Inhibitors for the Treatment of Refractory Solid Tumors
X Liang, S Tang, X Liu, Y Liu, Q Xu, X Wang, A Saidahmatov, C Li, ...
Journal of medicinal chemistry 65 (2), 1243-1264, 2021
452021
A proteomic and phosphoproteomic landscape of KRAS mutant cancers identifies combination therapies
Z Liu, Y Liu, L Qian, S Jiang, X Gai, S Ye, Y Chen, X Wang, L Zhai, J Xu, ...
Molecular Cell 81 (19), 4076-4090. e8, 2021
412021
SLC1A1-mediated cellular and mitochondrial influx of R-2-hydroxyglutarate in vascular endothelial cells promotes tumor angiogenesis in IDH1-mutant solid tumors
X Wang, Z Chen, J Xu, S Tang, N An, L Jiang, Y Zhang, S Zhang, Q Zhang, ...
Cell research 32 (7), 638-658, 2022
312022
Magnesium lithospermate B protects the endothelium from inflammation-induced dysfunction through activation of Nrf2 pathway
F Gao, J Li, C Xi, H Li, Y Liu, Y Wang, L Xuan
Acta Pharmacologica Sinica 40 (7), 867-878, 2019
222019
Magnesium lithospermate B ameliorates microcirculation perfusion in rats by promoting vascular NO production via activating the PI3K/AKT pathway
Y Liu, X Zhou, L Xuan
Acta Pharmacologica Sinica 40 (8), 1010-1018, 2019
142019
Investigation of the affordability of chronic diseases drug use in families from three provinces in Western China
F Liu, Y Liu, Q Chen, Y WU, C Zhang, S Pan, M HU
Chinese Journal of Health Policy, 54-58, 2017
42017
Oncogenic KRAS Induces Arginine Auxotrophy and Confers a Therapeutic Vulnerability to SLC7A1 Inhibition in Non–Small Cell Lung Cancer
X Gai, Y Liu, X Lan, L Chen, T Yuan, J Xu, Y Li, Y Zheng, Y Yan, L Yang, ...
Cancer Research 84 (12), 1963-1977, 2024
32024
A proteomic landscape of pharmacologic perturbations for functional relevance
Z Liu, S Jiang, B Hao, S Xie, Y Liu, Y Huang, H Xu, C Luo, M Huang, ...
Journal of Pharmaceutical Analysis 14 (1), 128-139, 2024
12024
Genomic and transcriptomic analyses of chemical hepatocarcinogenesis aggravated by loss of oncoproteins in hepatocytes
X Wang, J Zhang, Y Liu, S Zhang, Y Liang, M Zong, X Lin, M Karin, ...
Cancer Research 84 (6_Supplement), 2274-2274, 2024
2024
Low‐Dose Chemotherapy Preferentially Shapes the Ileal Microbiome and Augments the Response to Immune Checkpoint Blockade by Activating AIM2 Inflammasome in Ileal Epithelial Cells
C Pu, Y Li, Y Fu, Y Yan, S Tao, S Tang, X Gai, Z Ding, Z Gan, Y Liu, S Cao, ...
Advanced Science 11 (11), 2304781, 2024
2024
Genomic and transcriptomic analyses of chemical hepatocarcinogenesis aggravated by oncoprotein loss
X Wang, Y Liu, S Zhang, J Zhang, X Lin, Y Liang, M Zong, KL Hanley, ...
Hepatology, 10.1097, 2024
2024
NCOA5 Deficiency in Macrophages Provokes NASH and HCC
Y Liu, GS Feng
Cellular and Molecular Gastroenterology and Hepatology 17 (1), 171-172, 2024
2024
系统目前无法执行此操作,请稍后再试。
文章 1–13